एपीए उद्धरण

Feng, S., Zhou, L., Liu, Q., He, Q., Liao, B., Wei, X., . . . Zhu, Y. (2018). Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?: A systematic review and meta-analysis. Medicine (Baltimore).

शिकागो स्टाइल उद्धरण

Feng, Shijian, Liang Zhou, Qinyu Liu, Qing He, Banghua Liao, Xin Wei, Hong Li, Kunjie Wang, और Yuchun Zhu. "Are Phosphodiesterase Type 5 Inhibitors Associated With Increased Risk of Melanoma?: A Systematic Review and Meta-analysis." Medicine (Baltimore) 2018.

एमएलए उद्धरण

Feng, Shijian, et al. "Are Phosphodiesterase Type 5 Inhibitors Associated With Increased Risk of Melanoma?: A Systematic Review and Meta-analysis." Medicine (Baltimore) 2018.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.